| Maitri R Patel, MD | |
|
1881 Worcester Rd Ste 203, Framingham, MA 01701-5410 | |
| (508) 834-3183 | |
| (508) 532-1168 |
| Full Name | Maitri R Patel |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 24 Years |
| Location | 1881 Worcester Rd Ste 203, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912945213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 217414 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Progressive Therapeutics Llc | 9638234750 | 9 |
News Archive
Robert Avery, DO, MSCE, of Children's National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type of brain tumor.
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
New data demonstrating the anti-cancer activities of Oncoprex were presented at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) in Chicago, IL. The study, "Synergistic antitumor activity of AKT inhibitor MK2206 and FUS1 nanoparticles in LKB1 mutant NSCLC" (Meng J, Lara-Guerra H, Ji L, Roth JA) is authored by a team of investigators from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Entity Name | Progressive Therapeutics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386838266 PECOS PAC ID: 9638234750 Enrollment ID: O20090224000310 |
News Archive
Robert Avery, DO, MSCE, of Children's National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type of brain tumor.
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
New data demonstrating the anti-cancer activities of Oncoprex were presented at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) in Chicago, IL. The study, "Synergistic antitumor activity of AKT inhibitor MK2206 and FUS1 nanoparticles in LKB1 mutant NSCLC" (Meng J, Lara-Guerra H, Ji L, Roth JA) is authored by a team of investigators from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maitri R Patel, MD 1881 Worcester Rd Ste 203, Framingham, MA 01701-5410 Ph: (508) 834-3183 | Maitri R Patel, MD 1881 Worcester Rd Ste 203, Framingham, MA 01701-5410 Ph: (508) 834-3183 |
News Archive
Robert Avery, DO, MSCE, of Children's National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type of brain tumor.
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
New data demonstrating the anti-cancer activities of Oncoprex were presented at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) in Chicago, IL. The study, "Synergistic antitumor activity of AKT inhibitor MK2206 and FUS1 nanoparticles in LKB1 mutant NSCLC" (Meng J, Lara-Guerra H, Ji L, Roth JA) is authored by a team of investigators from The University of Texas MD Anderson Cancer Center.
› Verified 5 days ago
Joseph G. D'alton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 463 Worcester Rd, Suite 101, Framingham, MA 01701 Phone: 508-820-0469 Fax: 508-626-1985 | |
Adriana Neagoe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 945 Concord St, Framingham, MA 01701 Phone: 508-283-7898 Fax: 508-764-2462 | |
Ashley Lee Shepard, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 201, Framingham, MA 01702 Phone: 508-845-1110 | |
Dr. Sean Orin Mackintosh, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Frederick Abbott Way, Framingham, MA 01701 Phone: 508-879-9800 Fax: 508-875-1348 | |
Dr. James Allen Kennedy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 88 Lincoln St, Framingham, MA 01702 Phone: 508-879-9800 | |
Robert Merle Johnston, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 354 Waverly St, Advocates Inc., Framingham, MA 01702 Phone: 508-661-2020 | |
Dr. Jacob Goldberg, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 359 Union Ave, Framingham, MA 01702 Phone: 508-620-1919 Fax: 508-820-3093 |